UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 16,917 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 37.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 62,566 shares of the company's stock after purchasing an additional 16,917 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.15% of Phibro Animal Health worth $1,314,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of PAHC. Vanguard Group Inc. grew its position in Phibro Animal Health by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company's stock valued at $31,809,000 after acquiring an additional 20,604 shares during the last quarter. American Century Companies Inc. increased its stake in shares of Phibro Animal Health by 18.0% in the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock valued at $13,348,000 after buying an additional 96,787 shares during the period. Nuveen Asset Management LLC raised its stake in shares of Phibro Animal Health by 21.4% during the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock valued at $12,348,000 after acquiring an additional 103,618 shares during the last quarter. Renaissance Technologies LLC raised its stake in shares of Phibro Animal Health by 1.9% during the fourth quarter. Renaissance Technologies LLC now owns 557,800 shares of the company's stock valued at $11,714,000 after acquiring an additional 10,600 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Phibro Animal Health by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 515,979 shares of the company's stock worth $10,838,000 after purchasing an additional 8,510 shares during the period. Institutional investors own 99.34% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on PAHC. Morgan Stanley upped their target price on Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a report on Thursday, May 8th. Barclays upped their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research report on Monday, February 10th. Finally, Wall Street Zen raised Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Phibro Animal Health currently has a consensus rating of "Hold" and a consensus target price of $20.00.

Phibro Animal Health Stock Performance

NASDAQ:PAHC opened at $24.08 on Monday. Phibro Animal Health Co. has a twelve month low of $16.16 and a twelve month high of $26.55. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The firm has a market capitalization of $976.06 million, a P/E ratio of 50.17, a P/E/G ratio of 0.45 and a beta of 0.74. The company has a fifty day moving average of $20.78 and a 200-day moving average of $21.87.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. The company had revenue of $347.80 million for the quarter, compared to analyst estimates of $352.41 million. As a group, sell-side analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.99%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's payout ratio is 61.54%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Co. (NASDAQ:PAHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.